Company Directory > Pharma > Deloitte Tohmatsu Group
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Deloitte Tohmatsu Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Deloitte Tohmatsu Group is one of the largest professional services networks in Japan, operating as a member firm of the global Deloitte network. The group provides a comprehensive range of services, including audit and assurance, consulting, financial advisory, risk advisory, and tax services to a diverse client base ranging from multinational corporations to government agencies. With a history dating back to 1968, the organization leverages deep local expertise combined with global insights to address complex business challenges. It is organized into various specialized entities, such as Deloitte Tohmatsu Consulting and Deloitte Tohmatsu Financial Advisory, to deliver integrated, cross-functional solutions across industries including life sciences, technology, and finance.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:-
Industry:Consulting
Sub-Industry:Professional Services
SIZE & FINANCIALS
Employees:10000+
Founded:1968
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Parent Company:Deloitte Touche Tohmatsu Limited
Subsidiaries:Deloitte Tohmatsu Consulting LLC, Deloitte Tohmatsu Financial Advisory LLC, Deloitte Tohmatsu Tax Co., Deloitte Tohmatsu SPI Co., Ltd.
Key Partnerships:Global Deloitte network members, Various government agencies (METI, JICA)
COMPETITION
Position:Leader
Competitors:PwC Japan, EY Japan, KPMG Japan
LEADERSHIP
Key Executives:
Masato Sase - CEO, Deloitte Tohmatsu Consulting
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Deloitte Tohmatsu Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.